Genital Wart: Clinical Trials

1 trial for Genital Wart, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Genital Wart: new trials by email Literature Review of Genital Wart trials Research Report on Genital Wart

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years
Medium dose for 15-HPV vaccine, High dose for 15-HPV vaccine, Placebo - HPV Infection, HPV-Related Carcinoma
Phase 2RecruitingShanghai Bovax Biotechnology Co., Ltd.3302025-01-152025-12-17

Narrower conditions

Condylomata Acuminata (1)  ·  Papillomavirus Infections (1)

Broader conditions

Communicable Diseases (1)  ·  DNA Virus Infections (1)  ·  Disease Attributes (1)  ·  Genital Diseases (1)  ·  Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Sexually Transmitted Diseases (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Infectious (1)  ·  Skin Diseases, Viral (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Tumor Virus Infections (1)  ·  Urogenital Diseases (1)

Sponsors

Shanghai Bovax Biotechnology Co., Ltd. (1)

Countries

China (1)

Top investigators

Yi Mo, Master (1)